rab-11.1 Antibody

What is RAB-11.1 and what cellular functions does it serve?

RAB-11.1 is a member of the small GTPase family that plays critical roles in cellular trafficking pathways. In Caenorhabditis elegans (C. elegans), RAB-11.1 is one of two RAB-11 subfamily members (alongside RAB-11.2), with both being most similar to mammalian Rab11a . As a key regulator of membrane trafficking, RAB-11.1 performs several essential cellular functions:

• Directs polarized exocytosis, particularly targeting endosomes to the apical plasma membrane

• Localizes to apically polarized structures in epithelial cells

• Facilitates the fusion of vesicles/compartments with the plasma membrane

• Regulates spindle alignment by modulating cytoskeleton dynamics

In C. elegans intestinal cells, RAB-11.1 demonstrates distinctive apical localization patterns and plays critical roles in membrane trafficking events . Research has shown that during Nematocida parisii (N. parisii) infection in C. elegans, RAB-11.1 is required for spore-containing compartments to fuse with the apical plasma membrane, highlighting its importance in polarized exocytosis processes .

What are the main applications of RAB-11.1 antibodies in research?

RAB-11.1 antibodies serve as valuable tools across multiple experimental approaches in cell biology and infectious disease research:

These antibodies have been particularly informative in tracking RAB-11.1 dynamics during infection processes. For example, during N. parisii infection in C. elegans, RAB-11.1 antibodies revealed dramatic relocation of the protein to spore coats during the shedding phase, approximately 41 hours post-infection .

How does RAB-11.1 in C. elegans compare to mammalian Rab11?

Understanding the relationship between C. elegans RAB-11.1 and mammalian Rab11 proteins is essential for translational research:

C. elegans has two RAB-11 subfamily members (RAB-11.1 and RAB-11.2), both most similar to mammalian Rab11a . In contrast, mammals possess three Rab11 subfamily proteins: Rab11a, Rab11b, and Rab25 . Despite these differences, conservation of function exists across species:

• Both C. elegans RAB-11.1 and mammalian Rab11a serve as markers of recycling endosomes

• Both play key roles in apical membrane trafficking in polarized epithelial cells

• Functional conservation enables cross-species investigations using antibodies with validated cross-reactivity

When selecting antibodies for cross-species studies, researchers should verify species reactivity, as some commercial Rab11 antibodies may recognize epitopes conserved across species boundaries .

What subcellular localization patterns are expected when using RAB-11.1 antibodies?

When employing RAB-11.1 antibodies in microscopy applications, researchers should anticipate specific subcellular distribution patterns that vary with cell type and physiological state:

• In normal C. elegans intestinal cells: Predominantly cytosolic with clear apical enrichment

• In polarized epithelial cells: Concentrated at apical plasma membrane and associated recycling endosomes

• During N. parisii infection in C. elegans: Dramatic redistribution to coat spores positioned along the apical face of intestinal cells

• During mitosis: Association with spindle structures

These localization patterns can change dramatically under different experimental conditions. For instance, in C. elegans infected with N. parisii, RAB-11.1 transitions from primarily cytosolic distribution to intensely coating vast numbers of pathogen spores at the apical intestinal surface . This dynamic redistribution has been confirmed using both antibody detection of endogenous protein and transgenic GFP::RAB-11 and RFP::RAB-11 markers .

How can I validate the specificity of a RAB-11.1 antibody for my experiments?

Rigorous validation of RAB-11.1 antibodies is essential for generating reliable experimental data. A comprehensive validation approach should include:

• Genetic validation:

  • Test antibody in RAB-11.1 knockout/knockdown systems (RNAi, CRISPR/Cas9)

  • Compare staining patterns in wild-type versus RAB-11.1-depleted samples

  • Ensure signal reduction correlates with protein depletion levels

• Multiple detection methods:

  • Cross-validate results using antibodies targeting different RAB-11.1 epitopes

  • Compare immunofluorescence patterns with fluorescently tagged RAB-11.1 proteins

  • Verify appropriate molecular weight (approximately 25 kDa) in Western blots

• Epitope verification:

  • For peptide-derived antibodies, perform peptide competition assays

  • Sequence analysis to ensure epitope differs from related proteins (especially RAB-11.2)

  • Consider cross-reactivity with other Rab family proteins

Research has demonstrated effective validation by comparing endogenous RAB-11.1 detected by antibodies with GFP::RAB-11.1 and RFP::RAB-11.1 transgene markers in C. elegans, confirming colocalization and antibody specificity .

What controls should be included when using RAB-11.1 antibodies in immunofluorescence?

Robust immunofluorescence experiments require comprehensive controls to ensure valid interpretation of RAB-11.1 staining patterns:

Studies have employed multiple complementary approaches for validating RAB-11.1 staining, including using both transgenic GFP::RAB-11.1 and RFP::RAB-11.1 markers alongside antibody staining to confirm specificity in C. elegans .

How do I optimize RAB-11.1 antibody concentration for Western blotting?

Achieving optimal signal-to-noise ratio for RAB-11.1 detection by Western blotting requires systematic optimization:

• Initial titration approach:

  • Begin with manufacturer's recommended dilution (typically 1:1000)

  • Test dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000)

  • Use positive control samples with known RAB-11.1 expression

• Sample preparation considerations:

  • Include appropriate detergents for membrane protein extraction

  • Consider using phosphatase inhibitors if studying RAB-11.1 modifications

  • Optimize protein loading amount (typically 10-30 μg total protein)

• Incubation parameters:

  • Compare short (1-2 hours room temperature) versus overnight (4°C) incubations

  • Optimize blocking conditions (BSA versus milk, concentration)

  • Adjust washing stringency based on background levels

A successfully optimized Western blot should show a clear band at approximately 25 kDa for RAB-11.1 , with minimal background and no significant non-specific bands. Validation with RAB-11.1 knockdown samples can confirm signal specificity.

What are the common challenges in detecting RAB-11.1 in different experimental systems?

Researchers face several technical challenges when working with RAB-11.1 antibodies across experimental systems:

• Homology issues:

  • High sequence similarity between RAB-11.1 and RAB-11.2 in C. elegans

  • Cross-reactivity between Rab11a, Rab11b, and Rab25 in mammalian systems

  • Solution: Use antibodies targeting divergent regions and validate with knockdown controls

• Expression and detection sensitivity:

  • Variable RAB-11.1 expression levels across tissues and conditions

  • Dynamic redistribution during cellular processes like infection

  • Solution: Optimize fixation, antibody concentration, and detection methods

• Technical variables:

  • Epitope masking by certain fixation methods

  • Antibody batch variability affecting consistency

  • Species cross-reactivity differences

  • Solution: Comprehensive validation with each new experimental system

Research has demonstrated that RAB-11.1 detection patterns can change dramatically under different conditions. During N. parisii infection in C. elegans, RAB-11.1 transitions from diffuse cytosolic localization to intensely labeling pathogen spores , requiring optimization of detection parameters to capture this dynamic range.

How can I distinguish between RAB-11.1 and RAB-11.2 in C. elegans using antibodies?

Differentiating between the highly similar RAB-11.1 and RAB-11.2 proteins in C. elegans presents a technical challenge requiring specialized approaches:

• Strategic antibody selection:

  • Target antibodies to regions where RAB-11.1 and RAB-11.2 sequences diverge

  • Validate specificity using parallel rab-11.1 and rab-11.2 knockdown experiments

  • Consider developing isoform-specific monoclonal antibodies

• Combined genetic and immunological approaches:

  • Use rab-11.1 and rab-11.2 null mutants or RNAi-treated animals for antibody validation

  • Create transgenic animals expressing differentially tagged versions of each protein

  • Employ tissue-specific promoters to identify differential expression patterns

• Functional correlation:

  • Phenotypic analysis reveals that rab-11.1 RNAi causes stronger effects than rab-11.2 in processes like N. parisii spore shedding

  • Leverage known functional differences to validate antibody specificity

  • Design rescue experiments with specific isoforms to confirm functional distinctions

Research has demonstrated that rab-11.2 knockdown can reduce RAB-11.1 expression levels due to sequence similarity, further complicating analysis . This highlights the importance of using multiple approaches to confidently distinguish between these closely related proteins.

What are the best approaches to study RAB-11.1 interactions with other trafficking components?

Investigating RAB-11.1's protein interaction network requires sophisticated methodological approaches:

• Biochemical interaction methods:

  • Immunoprecipitation with RAB-11.1 antibodies followed by mass spectrometry

  • Yeast two-hybrid screening with RAB-11.1 as bait

  • In vitro binding assays with purified components

  • Compare wild-type RAB-11.1 with GTP-locked and GDP-locked mutants

• Imaging-based interaction studies:

  • Co-localization analysis with potential interaction partners

  • FRET/FLIM to detect direct protein-protein interactions

  • Proximity ligation assays using antibody pairs

  • Live-cell imaging of dynamic interactions

• Functional interaction analysis:

  • Genetic interaction studies between RAB-11.1 and other trafficking regulators

  • Analyze phenotypic outcomes of combined knockdowns (e.g., RAB-11.1 with RAB-5 or RAB-10)

  • Epistasis analysis to determine pathway relationships

Research has revealed important functional relationships between RAB-11.1 and other trafficking regulators. For example, while RAB-11.1 directly mediates spore-containing compartment fusion with the apical membrane in C. elegans, RAB-5 and RAB-10 appear to function in parallel or downstream pathways .

How do I design experiments to investigate RAB-11.1's role in polarized exocytosis?

Designing comprehensive experiments to elucidate RAB-11.1's function in polarized exocytosis requires multiple complementary approaches:

• Loss-of-function analysis:

  • RNAi-mediated knockdown of RAB-11.1

  • CRISPR/Cas9-generated knockouts or specific mutations

  • Expression of dominant-negative RAB-11.1 constructs

• Visualization strategies:

  • Fluorescently tagged RAB-11.1 for live-cell imaging (GFP::RAB-11.1, RFP::RAB-11.1)

  • Co-visualization with cargo and membrane markers

  • Super-resolution microscopy for detailed localization patterns

• Quantitative exocytosis assays:

  • Measure fusion events at the apical membrane

  • Analyze cargo trafficking kinetics

  • Quantify polarized secretion using compartment-specific markers

• Model system selection:

  • N. parisii infection in C. elegans as a model for studying RAB-11.1-dependent exocytosis

  • Polarized epithelial cell cultures

  • Developing embryos for analyzing polarity establishment

Research using N. parisii infection in C. elegans demonstrated that RAB-11.1 depletion causes a near-complete block in spore-containing compartment fusion with the apical membrane . Quantitative analysis revealed dramatic differences in fusion events between control and RAB-11.1-depleted animals, establishing RAB-11.1's essential role in this polarized exocytosis process .

What techniques can be combined with RAB-11.1 antibodies to study its GTPase activity?

Investigating RAB-11.1's GTPase cycle requires combining antibody-based detection with specialized biochemical approaches:

• Activity-state specific detection:

  • Pulldown assays using GTP-binding domains of RAB-11.1 effectors

  • Antibodies that preferentially recognize GTP- or GDP-bound conformations

  • Ratio measurement of active versus total RAB-11.1

• GTPase activity measurements:

  • In vitro GTPase assays with immunoprecipitated RAB-11.1

  • Phosphate release quantification

  • Analysis of nucleotide binding and exchange rates

• Functional correlation approaches:

  • Expression of constitutively active (Q70L) or dominant negative (S25N) RAB-11.1 mutants

  • Analysis of phenotypic outcomes related to GTPase cycle disruption

  • Correlation of activation state with subcellular localization patterns

• Effector binding analysis:

  • Co-immunoprecipitation of RAB-11.1 with effector proteins

  • Competition assays to study effector binding dynamics

  • Correlation of effector recruitment with specific cellular processes

These techniques could be applied to understand how RAB-11.1's GTPase cycle regulates processes like the polarized exocytosis of N. parisii spores in C. elegans , potentially revealing how RAB-11.1 activation correlates with its recruitment to specific structures like spore-containing compartments.